Pharmaceutical Products

Pharmaceutical Products - Pharmaceutical Products

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
Pharmaceutical Products Gene defects in humans can lead to deficiencies in proteins, such as insulin, human growth  hormone, and Factor VIII that may result in problems, such as diabetes, dwarfism, and impaired  blood clotting, respectively. Proteins for these chemicals can now be replaced by proteins  manufactured through biotechnology. For insulin production, two protein chains are encoded by  separate genes in plasmids inserted into bacteria. The protein chains are then chemically joined to  form the final insulin product. Human growth hormone is also produced within bacteria, but special  techniques are used because the bacteria do not usually produce human proteins. Therapeutic proteins, such as the following, can also be produced by biotechnology:  Tissue plasminogen activator (TPA) , a clot-dissolving protein, can now be  produced in recombined mammalian cells. 
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 11/11/2011 for the course BIO 101 taught by Professor Pesthy during the Fall '07 term at Texas State.

Ask a homework question - tutors are online